PharmaCyte Biotech Cash from Operations (TTM) Analysis

PharmaCyte Biotech Inc (PMCB)

2.10 -0.02 (-0.94%) USD | NASDAQ | Apr 26, 10:26

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2004. Upgrade now.

Date	Value
January 31, 2024	-2.107M
October 31, 2023	-2.472M
July 31, 2023	-2.366M
April 30, 2023	-3.794M
January 31, 2023	-4.697M
October 31, 2022	-4.454M
July 31, 2022	-3.960M
April 30, 2022	-4.117M
January 31, 2022	-3.866M
October 31, 2021	-4.156M
July 31, 2021	-4.021M
April 30, 2021	-3.331M
January 31, 2021	-3.03M
October 31, 2020	-2.793M
July 31, 2020	-2.126M
April 30, 2020	-2.338M
January 31, 2020	-2.360M
October 31, 2019	-2.685M
July 31, 2019	-3.019M
April 30, 2019	-2.878M
January 31, 2019	-3.591M
October 31, 2018	-4.087M
July 31, 2018	-4.766M
April 30, 2018	-5.079M
January 31, 2018	-4.506M

Date	Value
October 31, 2017	-4.258M
July 31, 2017	-3.368M
April 30, 2017	-3.340M
January 31, 2017	-3.757M
October 31, 2016	-3.843M
July 31, 2016	-4.190M
April 30, 2016	-4.346M
January 31, 2016	-4.219M
October 31, 2015	-4.273M
July 31, 2015	-4.837M
April 30, 2015	-4.560M
January 31, 2015	-4.407M
October 31, 2014	-3.592M
July 31, 2014	-2.182M
April 30, 2014	-1.555M
January 31, 2014	-0.7594M
October 31, 2013	-0.5873M
July 31, 2013	-0.4647M
April 30, 2013	-0.3904M
January 31, 2013	-0.2994M
October 31, 2012	-0.258M
July 31, 2012	-0.2251M
April 30, 2012	-0.2593M
January 31, 2012	-0.3492M
October 31, 2011	-0.382M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-4.697M

Minimum

Jan 2023

-2.107M

Maximum

Jan 2024

-3.228M

Average

-3.024M

Median

Cash from Operations (TTM) Benchmarks